New and Persistent Sedative Prescriptions Among Older Adults Following a Critical Illness : A Population-Based Cohort Study
Copyright © 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved..
BACKGROUND: ICU survivors often have complex care needs and can experience insufficient medication reconciliation and polypharmacy. It is unknown which ICU survivors are at risk of new sedative use posthospitalization.
RESEARCH QUESTION: For sedative-naive, older adult ICU survivors, how common is receipt of new and persistent sedative prescriptions, and what factors are associated with receipt?.
STUDY DESIGN AND METHODS: This population-based cohort study included ICU survivors aged ≥ 66 years who had not filled sedative prescriptions within ≤ 6 months before hospitalization (sedative-naive) in Ontario, Canada (2003-2019). Using multilevel logistic regression, demographic, clinical, and hospital characteristics and their association with new sedative prescription within ≤ 7 days of discharge are described. Variation between hospitals was quantified by using the adjusted median OR. Factors associated with persistent prescriptions (≤ 6 months) were examined with a multivariable proportional hazards model.
RESULTS: A total of 250,428 patients were included (mean age, 76 years; 61% male). A total of 15,277 (6.1%) filled a new sedative prescription, with variation noted across hospitals (2% [95% CI, 1-3] to 44% [95% CI, 3-57]); 8,458 (3.4%) filled persistent sedative prescriptions. Adjusted factors associated with a new sedative included: discharge to long-term care facility (adjusted OR [aOR], 4.00; 95% CI, 3.72-4.31), receipt of inpatient geriatric (aOR, 1.95; 95% CI, 1.80-2.10) or psychiatry (aOR, 2.76; 95% CI, 2.62-2.91) consultation, invasive ventilation (aOR, 1.59; 95% CI, 1.53-1.66), and ICU length of stay ≥ 7 days (aOR, 1.50; 95% CI, 1.42-1.58). The residual heterogeneity between hospitals (adjusted median OR, 1.43; 95% CI, 1.35-1.49) had a stronger association with new sedative prescriptions than the Charlson Comorbidity Index score or sepsis. Factors associated with persistent sedative use were similar with the addition of female subjects (subdistribution hazard ratio, 1.07; 95% CI, 1.02-1.13) and pre-existing polypharmacy (subdistribution hazard ratio, 0.88; 95% CI, 0.80-0.93).
INTERPRETATION: One in 15 sedative-naive, older adult ICU survivors filled a new sedative within ≤ 7 days of discharge; more than one-half of these survivors filled persistent prescriptions. New prescriptions at discharge varied widely across hospitals and represent the potential value of modifying prescription practices, including medication review and reconciliation.
Errataetall: |
CommentIn: Chest. 2023 Jun;163(6):1346-1347. - PMID 37295872 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:163 |
---|---|
Enthalten in: |
Chest - 163(2023), 6 vom: 01. Juni, Seite 1425-1436 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Burry, Lisa D [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antipsychotic |
---|
Anmerkungen: |
Date Completed 12.06.2023 Date Revised 02.02.2024 published: Print-Electronic CommentIn: Chest. 2023 Jun;163(6):1346-1347. - PMID 37295872 Citation Status MEDLINE |
---|
doi: |
10.1016/j.chest.2022.12.033 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351217576 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM351217576 | ||
003 | DE-627 | ||
005 | 20240203231833.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.chest.2022.12.033 |2 doi | |
028 | 5 | 2 | |a pubmed24n1279.xml |
035 | |a (DE-627)NLM351217576 | ||
035 | |a (NLM)36610663 | ||
035 | |a (PII)S0012-3692(23)00011-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Burry, Lisa D |e verfasserin |4 aut | |
245 | 1 | 0 | |a New and Persistent Sedative Prescriptions Among Older Adults Following a Critical Illness |b A Population-Based Cohort Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.06.2023 | ||
500 | |a Date Revised 02.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Chest. 2023 Jun;163(6):1346-1347. - PMID 37295872 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: ICU survivors often have complex care needs and can experience insufficient medication reconciliation and polypharmacy. It is unknown which ICU survivors are at risk of new sedative use posthospitalization | ||
520 | |a RESEARCH QUESTION: For sedative-naive, older adult ICU survivors, how common is receipt of new and persistent sedative prescriptions, and what factors are associated with receipt? | ||
520 | |a STUDY DESIGN AND METHODS: This population-based cohort study included ICU survivors aged ≥ 66 years who had not filled sedative prescriptions within ≤ 6 months before hospitalization (sedative-naive) in Ontario, Canada (2003-2019). Using multilevel logistic regression, demographic, clinical, and hospital characteristics and their association with new sedative prescription within ≤ 7 days of discharge are described. Variation between hospitals was quantified by using the adjusted median OR. Factors associated with persistent prescriptions (≤ 6 months) were examined with a multivariable proportional hazards model | ||
520 | |a RESULTS: A total of 250,428 patients were included (mean age, 76 years; 61% male). A total of 15,277 (6.1%) filled a new sedative prescription, with variation noted across hospitals (2% [95% CI, 1-3] to 44% [95% CI, 3-57]); 8,458 (3.4%) filled persistent sedative prescriptions. Adjusted factors associated with a new sedative included: discharge to long-term care facility (adjusted OR [aOR], 4.00; 95% CI, 3.72-4.31), receipt of inpatient geriatric (aOR, 1.95; 95% CI, 1.80-2.10) or psychiatry (aOR, 2.76; 95% CI, 2.62-2.91) consultation, invasive ventilation (aOR, 1.59; 95% CI, 1.53-1.66), and ICU length of stay ≥ 7 days (aOR, 1.50; 95% CI, 1.42-1.58). The residual heterogeneity between hospitals (adjusted median OR, 1.43; 95% CI, 1.35-1.49) had a stronger association with new sedative prescriptions than the Charlson Comorbidity Index score or sepsis. Factors associated with persistent sedative use were similar with the addition of female subjects (subdistribution hazard ratio, 1.07; 95% CI, 1.02-1.13) and pre-existing polypharmacy (subdistribution hazard ratio, 0.88; 95% CI, 0.80-0.93) | ||
520 | |a INTERPRETATION: One in 15 sedative-naive, older adult ICU survivors filled a new sedative within ≤ 7 days of discharge; more than one-half of these survivors filled persistent prescriptions. New prescriptions at discharge varied widely across hospitals and represent the potential value of modifying prescription practices, including medication review and reconciliation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a antipsychotic | |
650 | 4 | |a benzodiazepine | |
650 | 4 | |a critical care | |
650 | 4 | |a nonbenzodiazepine | |
650 | 4 | |a posthospitalization | |
650 | 4 | |a sedatives | |
650 | 7 | |a Hypnotics and Sedatives |2 NLM | |
700 | 1 | |a Bell, Chaim M |e verfasserin |4 aut | |
700 | 1 | |a Hill, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Pinto, Ruxandra |e verfasserin |4 aut | |
700 | 1 | |a Scales, Damon C |e verfasserin |4 aut | |
700 | 1 | |a Bronskill, Susan E |e verfasserin |4 aut | |
700 | 1 | |a Williamson, David |e verfasserin |4 aut | |
700 | 1 | |a Rose, Louise |e verfasserin |4 aut | |
700 | 1 | |a Fu, Longdi |e verfasserin |4 aut | |
700 | 1 | |a Fowler, Robert |e verfasserin |4 aut | |
700 | 1 | |a Martin, Claudio M |e verfasserin |4 aut | |
700 | 1 | |a Dolovich, Lisa |e verfasserin |4 aut | |
700 | 1 | |a Wunsch, Hannah |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chest |d 1970 |g 163(2023), 6 vom: 01. Juni, Seite 1425-1436 |w (DE-627)NLM000002720 |x 1931-3543 |7 nnns |
773 | 1 | 8 | |g volume:163 |g year:2023 |g number:6 |g day:01 |g month:06 |g pages:1425-1436 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.chest.2022.12.033 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 163 |j 2023 |e 6 |b 01 |c 06 |h 1425-1436 |